Welcome to our dedicated page for Odysight.ai SEC filings (Ticker: ODYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Odysight.ai Inc. (NASDAQ: ODYS) SEC filings page on Stock Titan provides access to the company’s regulatory documents as filed with the U.S. Securities and Exchange Commission. Odysight.ai is a Nevada corporation whose common stock is listed on the Nasdaq Capital Market under the symbol ODYS, and its filings offer detailed information on its AI-powered visual sensing, Predictive Maintenance (PdM), and Condition-Based Monitoring (CBM) business.
Among the key filings are Form 10-K annual reports and related documents, which, as referenced in company press releases, discuss Odysight.ai’s operations, risk factors, and financial statements. Form 8-K current reports, such as those dated August 13, 2025 and November 13, 2025, furnish press releases announcing financial results and business updates, while other 8-K filings cover events like updated investor presentations and executive appointments.
Odysight.ai has also filed a Form S-1 registration statement related to the resale of common stock by selling stockholders, which describes the company’s business overview, corporate history, subsidiaries in Israel and Europe, and its focus on visual-based PdM and CBM solutions. A DEF 14A definitive proxy statement outlines matters for stockholder votes, including director elections, executive compensation advisory votes, share incentive plan amendments, and auditor ratification.
On Stock Titan, users can review these filings in one place and use AI-powered summaries to understand lengthy documents such as 10-Ks, S-1 registration statements, and proxy materials. The platform also surfaces real-time updates from EDGAR, making it easier to track new Odysight.ai filings, interpret financial and operational disclosures, and follow governance items presented to shareholders.
Odysight.ai Inc. is adding a dual listing for its common stock on the Tel Aviv Stock Exchange. The shares have been approved for listing, with trading on TASE expected to begin on April 9, 2026 under the ticker ODYS (also “אודס” in Hebrew).
The stock will continue to trade on the Nasdaq Capital Market while also being traded on TASE in Israeli Shekels. The company states that the dual listing is intended to broaden its investor base, enhance trading liquidity, improve accessibility for Israeli and international investors, and strengthen its presence in the Israeli capital market as part of its long-term global growth strategy.
Odysight.ai Inc. reported that investors exercised previously issued warrants, leading to the issuance of new shares without the company receiving cash. These warrants came from a March 2023 private placement of 3,294,117 units, each containing one share of common stock and one warrant with a $5.50 exercise price.
On March 25, 2026, the investors exercised all of these warrants on a cashless basis, and the company issued 407,497 shares of common stock as a result. The transaction was conducted as an unregistered sale of equity securities and relates back to terms originally disclosed in an earlier Form 8-K.
Odysight.ai Inc. director and 10% owner Moshe Arkin, through Phoenix Insurance Company Ltd., exercised warrants for 2,352,941 shares of common stock at $5.50 per share in a cashless transaction. The issuer withheld 2,081,044 shares to cover the exercise price and issued 271,897 net shares.
After these transactions, Phoenix Insurance Company Ltd. held 2,624,838 shares of common stock indirectly for Arkin. Separately, M. Arkin (1999) Ltd. is reported as holding 2,959,143 shares of common stock and warrants for 222,223 shares, with no transactions effected in those securities and their inclusion stated as informational only.
Odysight.ai reported full year 2025 revenue of $3.0 million, down from about $4.0 million in 2024, as it wound down a legacy Fortune 500 medical contract and shifted toward aerospace, defense, and industrial predictive maintenance and condition-based monitoring.
Core vision-based PdM/CBM platform revenue grew about 23% year-over-year to $1.2 million, and backlog reached roughly $13.8 million as of December 31, 2025, supporting future revenue. Gross margin held near 29%, but operating expenses increased to $19.0 million from $13.7 million as the company invested in product development, sales and marketing, global expansion, and Nasdaq uplisting costs.
Net loss widened to $17.0 million from $11.8 million. Odysight.ai ended 2025 with approximately $26 million in cash, up from about $18.5 million, and no debt, after a February 2025 underwritten public offering that raised about $23.7 million in gross proceeds. Management is also exploring a potential dual listing on the Tel Aviv Stock Exchange.
Odysight.ai Inc. is a Nevada-based company developing vision-based sensor and AI/ML solutions for real-time condition-based monitoring and predictive maintenance in aerospace, defense, transportation, energy and industrial markets. Its systems use micro visual sensors, edge AI and cloud analytics to detect anomalies, reduce downtime and improve safety in hard-to-reach and harsh environments.
The company reports that most recent revenues were highly concentrated, with three customers accounting for approximately 98% of 2024 and 2025 revenue, and that sales cycles are long and unpredictable. Odysight.ai remains loss-making, with an accumulated deficit of about $63 million and net losses of $17 million in 2025 and $11.8 million in 2024, and expects to require additional capital before reaching profitability.
Management highlights a large predictive maintenance market, citing an estimated $14 billion global market in 2025 projected to grow to roughly $82 billion by 2031, and an aerospace total addressable market above $10 billion. As of June 30, 2025, non-affiliate market value was $35 million, and as of March 18, 2026, there were 16,359,410 common shares outstanding. The report emphasizes dependence on key customers and suppliers, extensive competition, and operational, regulatory, cybersecurity and geopolitical risks, including exposure to Israeli political and security conditions and obligations tied to Israeli Innovation Authority grants.
Odysight.ai Inc. reported that Chief Business Officer Sagi Eilam received a grant of stock options covering 15,000 shares of common stock at an exercise price of $0.0000 per share. The options vest one-third on November 15, 2026 and then in equal quarterly installments through November 15, 2028.
Odysight.ai Inc. reported insider option adjustments for director Benad Goldwasser. On February 19, 2026, the board approved a three-year extension of his stock option terms, implemented by canceling existing options and granting equivalent "replacement" options to purchase common stock in two blocks of 248,411 and 69,796 options.
Odysight.ai Inc. is registering up to $200,000,000 of securities, including common stock, subscription rights, debt securities, warrants and units, under a mixed shelf registration statement. This structure lets the company issue these securities in one or more offerings using a base prospectus and future supplements.
The securities may be sold through public or private transactions, directly or via underwriters, agents or dealers, at market or negotiated prices. As of January 29, 2026, Odysight.ai’s common stock traded on the Nasdaq Capital Market under the symbol “ODYS” at $6.10 per share, with 16,357,327 shares outstanding and an aggregate market value of non‑affiliate holdings of $52,821,608. The filing relies on General Instruction I.B.6, limiting sales under this registration to no more than one-third of that public float in any 12‑month period, and the company states it has not sold any securities under this rule in the prior 12 months. Unless a supplement states otherwise, net proceeds are expected to support research and development, sales and marketing, working capital and general corporate purposes.
Odysight.ai Inc. reported that its Chief Business Officer, Eilam Sagi, received a grant of stock options on January 25, 2026. The award covers options to purchase 60,000 shares of common stock at an exercise price of $4.7 per share, with no cash paid for the grant itself.
According to the vesting terms, the option becomes exercisable for one-third of the shares on November 15, 2026, then vests in equal quarterly installments over the following 24 months, so that it is fully vested and exercisable on November 15, 2028. After this grant, Sagi beneficially owns 60,000 derivative securities directly.